221 related articles for article (PubMed ID: 24357144)
1. Risedronate improves bone architecture and strength faster than alendronate in ovariectomized rats on a low-calcium diet.
Yano T; Yamada M; Konda T; Shiozaki M; Inoue D
J Bone Miner Metab; 2014 Nov; 32(6):653-9. PubMed ID: 24357144
[TBL] [Abstract][Full Text] [Related]
2. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
4. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
[TBL] [Abstract][Full Text] [Related]
5. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.
Yano T; Yamada M; Inoue D
Calcif Tissue Int; 2017 Jul; 101(1):102-110. PubMed ID: 28337514
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats.
Samnegård E; Iwaniec UT; Cullen DM; Kimmel DB; Recker RR
Bone; 2001 Mar; 28(3):251-60. PubMed ID: 11248654
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
[TBL] [Abstract][Full Text] [Related]
8. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model.
Mosekilde L; Danielsen CC; Søgaard CH; McOsker JE; Wronski TJ
Bone; 1995 Feb; 16(2):223-30. PubMed ID: 7756051
[TBL] [Abstract][Full Text] [Related]
9. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
[TBL] [Abstract][Full Text] [Related]
10. The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.
Shiraishi A; Miyabe S; Nakano T; Umakoshi Y; Ito M; Mihara M
BMC Musculoskelet Disord; 2009 Jun; 10():66. PubMed ID: 19527501
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):333-42. PubMed ID: 16880680
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance.
Ke CH; Li HY; Yang D; Ying H; Xu J; Wang J; Zhu HW; Wang L
Orthop Surg; 2021 Dec; 13(8):2433-2441. PubMed ID: 34676672
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
[TBL] [Abstract][Full Text] [Related]
14. Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Dec; 52(6):393-401. PubMed ID: 17330501
[TBL] [Abstract][Full Text] [Related]
15. Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.
Fuchs RK; Phipps RJ; Burr DB
J Bone Miner Res; 2008 Oct; 23(10):1689-97. PubMed ID: 18466070
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.
Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100
[TBL] [Abstract][Full Text] [Related]
17. Comparison of calcitonin, alendronate and fluorophosphate effects on ovariectomized rat bone.
Giavaresi G; Fini M; Gnudi S; Aldini NN; Rocca M; Carpi A; Giardino R
Biomed Pharmacother; 2001 Sep; 55(7):397-403. PubMed ID: 11669503
[TBL] [Abstract][Full Text] [Related]
18. The effect of rosiglitazone on bone mass and fragility is reversible and can be attenuated with alendronate.
Kumar S; Hoffman SJ; Samadfam R; Mansell P; Jolette J; Smith SY; Guldberg RE; Fitzpatrick LA
J Bone Miner Res; 2013 Jul; 28(7):1653-65. PubMed ID: 23456892
[TBL] [Abstract][Full Text] [Related]
19. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.
Iwamoto J; Takeda T; Sato Y; Yeh JK
Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
